Cardiovascular effects of Helichrysum ceres S Moore [Asteraceae] ethanolic leaf extract in some experimental animal paradigms

Cardiovascular Journal of Africa

Volumn 19, Issue 5, 2008, Pages 246-253

  Musabayane, Cephas T ^a   Kamadyaapa, Dave R ^a   Gondwe, Mavuto ^a   Moodley, Kogi ^a   Ojewole, John A O ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIUM DERIVED CONSTRICTING FACTOR; HELICHRYSUM CERES EXTRACT; HELICHRYSUM EXTRACT; N(G) NITROARGININE METHYL ESTER; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; ASTERACEAE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CHRONOTROPISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; GENETICALLY HYPERTENSIVE RAT; HEART ATRIUM MUSCLE; HEART BEAT; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART PERFORMANCE; HEART RATE; HELICHRYSUM; HELICHRYSUM CERES; HYPERTENSION; INOTROPISM; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLANT LEAF; PORTAL VEIN; RAT; THORACIC AORTA; TREATMENT DURATION; VASCULAR ENDOTHELIUM; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; AORTA; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; ENDOTHELIUM, VASCULAR; HEART RATE; HELICHRYSUM; MALE; MYOCARDIUM; PLANT EXTRACTS; PORTAL VEIN; RATS; RATS, WISTAR; VASODILATION;

EID: 56549126438     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Myers MG, Harris L. Antiarrhythmic drugs. In: Kalant H, ed. Principles of Medical Pharmacology, 4th edn. New York: Oxford University, 1985: 411-424.
2. Osim EE, Mbajiorgu EF, Mukarati G, Makufa B, Munjeri O, Musabayane CT. Hypotensive effect of crude extract of Olea africana (Oleaceae) in normotensive and hypertensive rats. Cent Afr Med J 1996; 45: 269-274.
3. Somova IL, Shode FO, Nadar A, Ramnanan P. Antihypertensive, antiatheroscleritic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J Ethnopharmacol 2003; 84: 299-305.
4. Miller AL. Botanical influences on cardiovascular disease. Altern Med Rev 1998; 3(6): 422-431.
5. Van Wyk B-E, Van Oudtshoorn B, Gericke N. Medicinal Plants of South Africa, 2nd edn. Pretoria: Briza, 2002: 148.
6. Hutchings A. Observations on plant usage in Xhosa and Zulu medicine. Bothalia 1989; 19: 225-235.
7. Musabayane CT, Munjeri O, Mdege ND. Effects of Helichrysum ceres extracts on renal function and blood pressure in the rat. Renal Fail 2003; 25: 5-14.
8. Sheila A, Doggrell SA, Brown L Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 1998; 39: 89-105.
9. Dahl LK, Heine M, Tassinari L. Effects of chronic salt ingestion: evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 1962; 115: 1173-1190.
10. Musabayane CT, Gondwe M, Kamadyaapa DR, Chuturgoon AA, Ojewole JAO. Effects of Ficus thonningii (Blume) [Morarceae] stembark ethanolic extract on blood glucose, cardiovascular and kidney functions of rats, and on kidney cell lines of the proximal (LLC-PK1) and distal tubules (MDBK). Renal Fail 2007; 29(4): 389-397.
11. Godfraind T, Kaba A. Blockade or reversal of the contraction induced by calcium and noradrenaline in depolarized arterial smooth muscle. Br J Pharmacol 1969; 81: 16-18.
12. Buckingham RE, Hamilton TC, Howlett DR, Mootoo S, Wilson C. Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol 1989; 97: 57-64.
13. + channels in arterial smooth muscles. Science 1989; 245(4914): 177-180.
14. + channel in rat ileal smooth muscle. Eur J Pharmacol 1994; 271: 379-386.
15. Hamilton TC, Weir SW, Weston TH. Comparison of the effects of BRL34915 and verapamil on electrical and mechanical activity of rat portal vein. Br J Pharmacol 1986; 88: 103-111.
16. Ito K, Kanno T, Suzuki K, Masuzawa-Ito K, Takewaki T, Ohashi H, et al. Effects of cromakalin on the contraction and the membrane potential of the circular smooth muscle of guinea-pig stomach. Br J Pharmacol 1992; 105: 335-340.
17. Navasa M, Bosch J, Rodes J. Pharmacological agents and portal hypertension. In: Okuda K, Benhamou JP, eds. Portal Hypertension: Clinical and Physiological Aspects. Berlin: Springer Verlag, 1991; 35-49.
18. Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986; 38: 321-416.
19. Ogbobe O. Phytochemical composition and characterization of the seed and seed oil of Sclerocarya birrea. Pl Foods Hum Natural 1992; 42(3):201-206.
20. Eromosele IC, Eromosele CO, Kuzhkuzha DM. Evaluation of mineral elements and ascorbic acid contents in fruits of some wild plants. Pl Foods Hum Natural 1991; 41(2): 151-154.
21. Galvez J, Crespo ME, Zarzuelo A, De Witte P, Spiessens C. Pharmacological activity of a procyanidin isolated from Sclerocarye birrea bark: antidiarrhoeal activity and effects on isolated guinea-pig ileum. Phytother Res 1993; 7: 25-28.
22. Fitzpatrick DF, Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol 1995; 26: 90-95.
23. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavanoids and phenolic acids. Free Rad Biol Med 1996; 20: 933-956.
24. Andriambeloson E, Stoclet JC, Andriantsitohaina R. Pharmacological approaches of endothelial nitric oxide-dependent vasorelaxation induced by polyphenols from plant extracts. Meth Enzymol 1999; 301: 522-532.
25. Lacaille-Dubois MA, Frank U, Wagner H. Search for potential Angiotensin Converting Enzyme (ACE) inhibitors from plants. Phytomedicine 2001; 8(1): 47-52.
26. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precussor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251-1256.
27. Rees DD, Palme, RM, Hodson HF, Moncada SA. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989; 96: 418-424.
28. L- arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 1990; 99: 408-412.
29. Baisch ALM, Urban H, Ruiz AN. Endothelium-dependent vasorelaxing activity of aqueous extracts of lyophilized seeds of Casimiora edulis (AECe) on rat mesenteric arterial bed. J Ethnopharmacol 2004; 95: 163-167.
30. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993; 45: 367-374.
31. Kawada T, Ishibashi T, Sasage H, Kato K, Imai S. Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atripeptin in aortae of the rat, guinea-pig and rabbit. Gen Pharmacol 1994; 25: 1361-1371.
32. Shi CC, Liao JF, Chen CF. Spasmolytic effects of three harmala alkaloids on guinea-pig isolated trachea. Pharmacol Toxicol 2001; 89: 259-64.
33. Archer SL, Huang JM, Hampl V, Nelson DP, Schultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci 1994; 91: 7583-7587.
34. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 1990; 346: 69-71.
35. Bialecki BA, Stinson-Fisher C. K-Ca channel antagonists reduce NO donor-mediated relaxation of vascular and tracheal smooth muscles. Am J Physiol 1995; 268: L152-L159.
36. Robertson BE, Schubert R, Hescheler J, Nelson MT. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol 1993; 265: C299-C303.
37. + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflugers 1993; 423: 167-172.
38. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci 1977; 74: 3203-3207.
39. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. Guanylate cyclases and signaling by cyclic GMP. Pharmacol Rev 2000; 52: 375-414.
40. Hamilton TC, Weston TH. Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscles. Gen Pharmacol 1989; 20: 1-9.
41. Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. A Rev Pharmacol Toxicol 1993; 33: 597-637.
42. Kishil KI, Morimoto T, Nakajima N, Yamazaki K, Tsujitama M, Takayanagi L. Effects of LP-805, a novel vasorelaxant agent, a potassium channel opener, on rat thoracic aorta. Gen Pharmacol 1992; 23: 347-353.